EUVIMEDEUVIMED entdecken
Crossref

A 2‐week treatment with 5‐azacytidine improved the hypercontractility state in prostate from obese mice: Role of the nitric oxide‐cyclic guanosine monophosphate signalling pathway

Ana Carolina Ghezzi, Gabriela Reolon Passos, Mariana Gonçalves de Oliveira iD, Akila Lara Oliveira, Guilherme Rossi Assis-Mendonça, Glaucia Coelho de Mello, Edson Antunes, Fabiola Zakia Monica iD

Clinical and Experimental Pharmacology and Physiology · 2024

DOI: 10.1111/1440-1681.13851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, 2024. Verfasst von Ana Carolina Ghezzi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translation Medicine (Pharmacology area), Faculty of Medical Sciences, University of Campinas (Unicamp), Campinas, Brazil. Hauptthemen laut MEDLINE: Nitric Oxide, Prostatic Hyperplasia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível 516 Superior, São Paulo Research Foundation, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benign prostatic hyperplasia (BPH) is characterised by increases in prostate volume and contraction. Downregulation of the nitric oxide (NO)‐cyclic guanosine monophosphate (cGMP) signalling pathway contributes to prostate dysfunctions. Previous studies in cancer cells or vessels have shown that the epigenetic mechanisms control the gene and protein expression of the enzymes involved in the production of NO and cGMP. This study is aimed to evaluate the effect of a 2‐week treatment of 5‐azacytidine (5‐AZA), a DNA‐methyltransferase inhibitor, in the prostate function of mice fed with a high‐fat diet. Functional, histological, biochemical and molecular assays were carried out. Obese mice presented greater prostate weight, α‐actin expression and contractile response induced by the α‐1adrenoceptors agonist. The relaxation induced by the NO‐donor and the protein expression of endothelial nitric oxide synthase (eNOS) and soluble guanylate cyclase (sGC) were significantly decreased in the prostate of obese mice. The treatment with 5‐AZA reverted the higher expression of α‐actin, reduced the hypercontractility state of the prostate and increased the expression of eNOS and sGC and intraprostatic levels of cGMP. When prostates from obese mice treated with 5‐AZA were incubated in vitro with inhibitors of the NOS or sGC, the inhibitory effect of 5‐AZA was reverted, therefore, showing the involvement of NO and cGMP. In conclusion, our study paves the way to develop or repurpose therapies that recover the expression of eNOS and sGC and, hence, to improve prostate function in BPH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nitric OxideProstatic HyperplasiaMaleHumansMiceAnimalsGuanylate CyclaseProstateMice, ObeseGuanosine MonophosphateAzacitidineActinsCyclic GMP

Stichwörter der Autor:innen

DNA methyltransferase inhibitor. high fat dietbenign prostatic hyperplasianitric oxideobesity

Substanzen

Nitric OxideGuanylate CyclaseGuanosine MonophosphateAzacitidineActinsCyclic GMP

Autor:innen und Institutionen

  • Department of Translation Medicine (Pharmacology area), Faculty of Medical Sciences, University of Campinas (Unicamp), Campinas, Brazil.
  • Department of Pathology, Faculty of Medical Sciences, University of Campinas (Unicamp), Campinas, Brazil.
  • National Academy of Medicine, Young Leadership Physician Program, Rio de Janeiro, Brazil.

ORCID-Profile: Mariana Gonçalves de Oliveira, Fabiola Zakia Monica

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível 516 Superior
  • São Paulo Research Foundation
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Ghezzi, A. C., Passos, G. R., de Oliveira, M. G., Oliveira, A. L., Assis-Mendonça, G. R., de Mello, G. C., Antunes, E., & Monica, F. Z. (2024). A 2‐week treatment with 5‐azacytidine improved the hypercontractility state in prostate from obese mice: Role of the nitric oxide‐cyclic guanosine monophosphate signalling pathway. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.13851

Vancouver

Ghezzi AC, Passos GR, de Oliveira MG, Oliveira AL, Assis-Mendonça GR, de Mello GC, et al. A 2‐week treatment with 5‐azacytidine improved the hypercontractility state in prostate from obese mice: Role of the nitric oxide‐cyclic guanosine monophosphate signalling pathway. Clinical and Experimental Pharmacology and Physiology. 2024. doi:10.1111/1440-1681.13851

BibTeX
@article{Ghezzi2024,
  author = {Ghezzi, Ana Carolina and Passos, Gabriela Reolon and de Oliveira, Mariana Gonçalves and Oliveira, Akila Lara and Assis-Mendonça, Guilherme Rossi and de Mello, Glaucia Coelho and Antunes, Edson and Monica, Fabiola Zakia},
  title = {A 2‐week treatment with 5‐azacytidine improved the hypercontractility state in prostate from obese mice: Role of the nitric oxide‐cyclic guanosine monophosphate signalling pathway},
  journal = {Clinical and Experimental Pharmacology and Physiology},
  year = {2024},
  doi = {10.1111/1440-1681.13851}
}
Kostenlos starten →